Platelets are involved in life-sustaining processes such as hemostasis, wound healing,
atherothrombosis and angiogenesis. Mechanical trauma to blood vessels causes platelet …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

Patients with chronic kidney disease (CKD) represent an increasing proportion of the
population undergoing percutaneous coronary intervention (PCI) and up to 40% of the …

Background and aims: Percutaneous renal biopsy is a necessary tool to diagnose renal
diseases but complications may still occur. The aims of this study were to detect the rate of …

Coagulation involves a complex set of events that are important in maintaining hemostasis.
Biochemical interactions are classically known to regulate the hemostatic process, but …

Endothelial dysfunction, one of many causes of arterial changes in end-stage kidney
disease (kidney failure), is a likely link between early vascular aging and the risk of …

Background. Platelet function analysis utilizing platelet‐rich plasma and optical density
based aggregometry fails to identify patients at risk for uremia associated complications …

Background & Aims: Liver biopsy is useful for staging fibrosis in chronic hepatitis C (CHC)
patients with end-stage renal disease (ESRD) to determine renal transplant eligibility and to …

Background End-stage renal disease patients have significant cardiovascular morbidity and
mortality, but little is known about differences in coagulation profiles between patients on …

Background and aims Controlled attenuation parameter (CAP) is a non-invasive method for
measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely …